N-Boc-2-Pyrroleboronic Acid

Within multi-kilogram API campaigns targeting ATP-competitive kinase inhibitors, N-Boc-2-pyrroleboronic acid is employed as the nucleophilic partner in palladium-mediated cross-coupling with a heteroaryl bromide. The reaction is charged under nitrogen purge in a 200 L glass-lined reactor equipped with a retreat-curve impeller, maintaining a jacket temperature of 72 °C during reflux. A typical charge ratio is 1.05 eq of the boronic acid relative to 1.0 eq of the aryl halide, with 0.5 mol% Pd(PPh₃)₄ and 2.2 eq of anhydrous K₂CO₃ in a degassed THF/water mixture (3:1 v/v). Reaction progress is tracked via IPC-HPLC (C18 column, UV 254 nm) until the aryl bromide area drops below 0.5%. Post-reaction, the cooled crude is filtered through a pad of Celite-545 and extracted into MTBE. Residual palladium levels in the isolated intermediate frequently exceed 300 ppm before purification, making a scavenging step mandatory under ICH Q3D oral exposure limits. An optimized treatment with trimercaptotriazine-functionalized silica gel (10 wt% relative to crude, slurry stirred at 40 °C for 6 h) reproducibly depresses Pd to ≤ 10 ppm as quantified by ICP‑MS after microwave digestion. The resulting N-Boc-2-arylpyrrole then undergoes acidolytic deprotection using 3.0 M HCl in dioxane (4 eq) at 0–5 °C with active venting of isobutylene and CO₂ off-gas through a caustic scrubber; this step is executed in Hastelloy C‑22 equipment to resist chloride pitting. After solvent swap into ethanol and treatment with activated carbon, the free amine is converted into a besylate salt, meeting a final purity of ≥ 99.0 area% by HPLC and a single unknown impurity ≤ 0.15%. The plant batch record references ICH Q7 Section 8.3 for in-process controls and ICH Q3C Option 2 for residual solvent reporting, with acetone and MTBE residual levels validated to ≤ 25 µg/g each.

What Determines Residual Palladium Clearance Efficiency in N-Boc-2-pyrroleboronic Acid Based API Intermediates?

Pharmaceutical intermediates synthesised through Suzuki–Miyaura coupling of N-Boc-2-pyrroleboronic acid with electron-deficient pyridine or pyrimidine bromides encounter a persistent bottleneck at the palladium removal stage. The lipophilic Boc-protected pyrrole core coordinates Pd(0) species tenaciously, and simple charcoal treatment reduces Pd by barely 60–70%. On a pilot-plant run targeting a late-stage oncology intermediate, the Pd concentration in the THF concentrate spiked to 412 ppm after a standard Darco G‑60 treatment due to colloidal Pd reformation during distillation. Switching to a dual-scavenger bed — first a stationary phase of cysteine-immobilised silica and then a macroporous polystyrene-thiol resin — achieved ≤ 5 ppm Pd with 91% mass recovery in three successive 80 kg batches. The scavenging efficacy was monitored in-line using a Metrohm 946 Portable Voltammetric Analyzer, allowing real-time switching to bypass mode when the Pd signal fell below the 0.02 µA threshold. Each batch was released under a Certificate of Analysis that enumerates Pd, Cu, and Fe by ICP-MS following methods based on USP ⟨232⟩/⟨233⟩. This protocol supports an allowable daily intake of elemental palladium below 100 µg/day for the eventual oral solid dosage form. Deportation into the final Boc-deprotected intermediate forces registration of an active DMF with the US FDA citing controlled steps and impurity fate data under 21 CFR 314.420.

In a parallel process scale focused on a CNS-targeting molecule, the aqueous workup step after Suzuki coupling was found to generate emulsions that trapped up to 8% of the product in the rag layer. Insertion of a knife-edge coalescer (Pall PhaseSep EL, 0.6 µm pore size) between the reactor and the phase splitter decanter reduced product loss to 0.4% and shortened batch cycle time by 2.5 h. The final crystalline intermediate then enters a spray-dried dispersion formulation, where residual DMF from the coupling step is considered a critical impurity. Stripping DMF under a 50 mbar vacuum at 45 °C with a constant nitrogen sweep lowered DMF from 1200 ppm to ≤ 40 ppm, conforming with ICH Q3C Class 2 solvent limits without any solvent exchange step.

The terminal API derived from this intermediate, a selective receptor tyrosine kinase antagonist, must satisfy elemental impurity option 1 limits per ICH Q3D; the supply specification for N-Boc-2-pyrroleboronic acid therefore mandates a Cd content of ≤ 2 ppm, based on hot block digestion and GF-AAS detection. Vendors providing this boronic acid submit documentation demonstrating that the Pd catalyst lot used in its manufacture does not contain unary cadmium contamination from recycled metal streams, referencing the supply chain transparency clause of ISO 9001:2015 Section 8.4.

In agricultural chemistry, N-Boc-2-pyrroleboronic acid serves as a building block for novel pyrrole-amide insecticides targeting the γ-aminobutyric acid (GABA)-gated chloride channel of hemipteran pests. The initial Suzuki coupling employs a 2,6-dichloropyridine-4-boronate ester as the electrophilic counterpart under aqueous micellar conditions using 2 wt% TPGS-750-M surfactant in water, which eliminates flammable solvents and simplifies waste-water treatment. In a 500 L stainless-steel reactor with pitched-blade turbine agitation, the batch is charged at 20 °C with 1.02 eq of the boronic acid, 1.0 eq of the chloropyridine partner, 0.2 mol% Pd(OAc)₂, 0.8 mol% XPhos, and 1.5 eq K₃PO₄·H₂O. Exotherm upon catalyst activation raises the internal temperature to 32 °C within 15 min; cooling is applied immediately to keep the mixture below 35 °C to avoid pyrrole ring oxidation. Complete conversion is reached within 4 h, after which the reaction is diluted with brine and the crude product is extracted into minimal cyclopentyl methyl ether. Following a solvent switch to methanol, the intermediate crystallises at −10 °C with a purity exceeding 97 area%. The 2-arylpyrrole is then Boc‑deprotected with trifluoroacetic acid (3 eq) in DCM at 0 °C, quenched into ice-cold aqueous K₂CO₃, and directly acylated with pivaloyl chloride to generate the pro‑insecticide. The entire sequence is conducted in equipment exclusively dedicated to non-food-chain intermediates and documented under a quality manual aligned with FAO/WHO guidelines for pesticide specification development. Acute oral toxicity testing of the technical grade active ingredient according to OECD TG 423 is triggered only after residual TFA is confirmed to be ≤ 0.15 wt% by ion chromatography, as TFA itself interferes with the toxicological endpoint.

When Eliminating Background Fluorescence Requires Ultra-Low Metal Content in BODIPY Fluorophores

The synthesis of high-quantum-yield 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene dyes (BODIPY) that rely on a 2-arylpyrrole core derived from N-Boc-2-pyrroleboronic acid demands absolute control over paramagnetic metal quenchers. In a typical photophysics laboratory, after the Suzuki coupling between the boronic acid and an iodo-substituted benzaldehyde, the crude N-Boc-2-(4-formylphenyl)pyrrole is subjected to stringent metal reduction before the subsequent condensation. A protocol using a stirred suspension of the crude in ethyl acetate with 2 eq of dithiooxamide as scavenger, agitated at 60 °C for 12 h, removes residual Cu and Fe to levels below 0.5 ppm, as verified by total reflection X-ray fluorescence. Only material passing this limit is advanced to the deprotection-condensation cascade. Boc removal is performed with 1.5 eq of boron tribromide in dry DCM at −78 °C, warmed gradually to 0 °C, a method that simultaneously liberates the free pyrrole and scavenges trace nucleophilic impurities. The resulting 2-(4-formylphenyl)pyrrole is immediately treated with an additional equivalent of the same pyrrole and 1.1 eq of trimethyl orthoformate in the presence of catalytic BF₃·Et₂O to form the dipyrromethene intermediate. Oxidation with 1.2 eq DDQ in toluene at 23 °C, followed by complexation with BF₃·Et₂O and N-ethyldiisopropylamine, yields the BODIPY fluorophore after flash chromatography on basic alumina (activity grade III). The isolated dye exhibits an absorption maximum at 502 nm and an emission maximum at 515 nm in ethanol, with the Stokes shift measured to be 13 nm — a value consistent with a rigid, minimally solvatochromic fluorophore. Fluorescence quantum yield is determined to be 0.89 ± 0.03 using the comparative method of Williams et al. against fluorescein in 0.1 M NaOH (φref = 0.95), an approach aligned with the IUPAC technical report on quantum yield standards. Full width at half maximum of the emission band is 28 nm, indicating a homogeneous chromophore. These BODIPY dyes are integrated into lateral flow immunoassay test lines where the detection threshold for influenza B nucleoprotein requires a signal-to-noise ratio exceeding 12:1; any Pd residue above 2 ppm depresses photon counts by 18% due to static quenching, causing the assay to fall below the acceptable diagnostic sensitivity specified in CLSI EP17-A2.

Pilot-scale dye production for a commercial flow cytometry label uses a microreactor cascade to mitigate the strong exotherm during BF₃ complexation. The dipyrromethene solution is combined with 3.0 eq BF₃·Et₂O in a Corning Advanced-Flow G1 reactor with a residence time of 45 s at 15 °C, delivering a throughput of 12 g·h⁻¹ of crude BODIPY. The product is purified by recrystallisation from acetonitrile/methanol (9:1) to obtain a dye purity of ≥ 99.5 area% at 470 nm HPLC. The dried material is stored under argon in amber vials at −20 °C, as accelerated stability studies at 40 °C/75% RH show a 3% loss in quantum yield after 4 weeks when exposed to ambient light. Conjugation to monoclonal antibodies through the NHS ester derivative of the dye is performed immediately after dye activation, which is characterised by a mass shift of +176 Da confirmed via MALDI‑TOF MS. The degree of labeling is controlled at 4.2 ± 0.5 fluorophores per antibody, monitored by UV‑Vis absorbance ratio at 502 nm versus 280 nm.

Organic Field-Effect Transistor Donor Units Incorporating N-Boc-2-pyrroleboronic Acid

Alternating donor-acceptor copolymers for the active layer of p-type OFETs can assemble the donor block from a 2-aryl-pyrrole unit prepared by Suzuki polycondensation. N-Boc-2-pyrroleboronic acid is first converted in situ to the pinacol ester using pinacol and MgSO₄ as dehydrating agent; the esterified monomer is then copolymerised with a dibromo-isoindigo acceptor under microwave irradiation at 130 °C in a chlorobenzene/DMF mixture (4:1) containing 2 mol% Pd₂(dba)₃ and 8 mol% tris(2-methoxyphenyl)phosphine. Polymer molecular weight is targeted to Mn > 25 kDa and Đ < 2.1 as measured by high-temperature GPC in 1,2,4-trichlorobenzene at 150 °C with polystyrene calibration. The Boc group remains attached during polymerisation to enhance solubility, and it is removed quantitatively by thermal annealing the deposited thin film at 200 °C for 20 min under nitrogen, a procedure that releases isobutylene and CO₂ without leaving non-volatile residues. This annealing simultaneously improves the edge-on crystallite orientation, evidenced by a decrease in the π-π stacking distance from 3.8 Å to 3.5 Å derived from grazing-incidence X-ray diffraction. Tapping-mode AFM images of the deprotected film reveal interconnected fibrillar domains with a root-mean-square roughness of 0.8 nm, suitable for a dielectric interface. Bottom-gate top-contact OFET devices fabricated on octadecyltrichlorosilane-treated SiO₂ (300 nm thermal oxide) exhibit a saturation hole mobility of 0.42 cm²·V⁻¹·s⁻¹, a current on/off ratio exceeding 10⁶, and a threshold voltage of −3.5 V as extracted from transfer curves following IEEE Std 1620-2008 test structures. Operational stability under continuous bias stress at VGS = −40 V for 10⁴ s reveals a mobility loss of merely 4%, attributable to the absence of trapping sites from residual Boc fragments as shown by FT‑IR absence of the carbonyl band at 1700 cm⁻¹.

A variant application forms the donor-acceptor dyad for dye-sensitized solar cells. Here the boronic acid is coupled to a cyanoacrylic acid anchor via a 2,5-thiophene spacer, generating a push-pull chromophore that sensitizes anatase TiO₂ on FTO glass. Incident photon-to-current conversion efficiency peaks at 78% at 450 nm, with a short-circuit current density of 12.8 mA·cm⁻² under AM 1.5G irradiation calibrated with a silicon reference cell (ASTM G173-03). The Boc group is retained in this molecule to inhibit dye aggregation; its bulkiness increases the intermolecular distance and raises the open-circuit voltage by 60 mV relative to the des-Boc analogue. Electrochemical impedance spectroscopy confirms an electron lifetime of 45 ms under one-sun illumination, attributed to effective passivation of surface traps by the carbamate moiety.

A Pyrrole-Based Buchwald-Type Ligand Series Emerged from This Boronic Ester

N-Boc-2-pyrroleboronic acid becomes the pivot for synthesising 2-(dicyclohexylphosphino)pyrrole, a ligand deliberately designed to mimic the steric profile of SPhos but with enhanced solubility in hydrocarbon solvents. The boronic acid undergoes Suzuki coupling with 2-bromopyrrole-N-dicyclohexylphosphine oxide, followed by reduction of the phosphine oxide with HSiCl₃ and triethylamine in refluxing toluene. The resulting ligand is a white crystalline solid, which when combined with Pd₂(dba)₃ in a 1.2:1 L:Pd ratio catalyses the coupling of unactivated aryl chlorides with primary amines at 0.5 mol% loading. A representative coupling of 4-chlorotoluene with n-octylamine in the presence of 1.1 eq NaO^tBu in THF at 65 °C achieves a 98% GC yield with a turnover number of 196. The ligand´s pyrrole NH, unmasked after in situ removal of the Boc group with trace acid generated during the catalytic cycle, is believed to assist in deprotonation of the amine substrate via a concerted metalation-deprotonation pathway. This hypothesis is supported by a kinetic isotope effect of 2.8±0.2 when comparing ⁿBuNH₂ and ⁿBuND₂, and the system displays first-order dependence on both ligand and substrate concentration. The ligand is handled in a nitrogen-atmosphere glovebox; its ³¹P NMR chemical shift in C₆D₆ is −14.2 ppm, and it forms stable Pd(0) complexes as evidenced by a single-crystal X‑ray structure showing a P–Pd bond length of 2.28 Å. Scalability of ligand manufacture to 500 g batches is documented, with purification by flash chromatography on silica gel deactivated with 5% triethylamine/hexane.

Application of this ligand class in the preparation of a clinical candidate intermediate of a CRTH2 antagonist showcases a 10‑fold reduction in palladium loading relative to Pd/Xantphos, thereby cutting the metal scavenging burden in the downstream process to ≤ 20 ppm after treatment with activated carbon cloth alone. The consistent ligand quality is assured through a set of release tests including HPLC purity ≥ 99.0%, water content ≤ 0.1% by KF titration, and residual halide determined by ion chromatography, all referenced against the material specification aligned with ASTM E2847-21 for instrument calibration. Any batch failing to deliver a TON of ≥ 180 in the model aryl amination test is rejected for pharmaceutical synthesis.

N-Boc-2-pyrroleboronic acid has been deployed in the total synthesis of the macrocyclic marine metabolite dragmacidin E, a protein kinase C inhibitor. A key intermediate, a 2,3′-biindolyl-pyrrole fragment, is constructed by a one-pot double Suzuki-Miyaura-Miyaura coupling. The boronic acid (2.5 eq) is first reacted with 4-iodo-N-tosylindole using 5 mol% PdCl₂(dppf)·CH₂Cl₂ and CsF (3 eq) in DME/water at 80 °C, then the second iodoindole unit is introduced after 8 h without isolation, affording the unsymmetrical terpyrrole intermediate in 61% isolated yield after silica gel chromatography. The Boc protecting group remains intact through all subsequent operations — a Grignard addition and a macrocyclization via ring-closing metathesis — and is removed only in the final step using LiCl in wet DMSO at 90 °C to avoid acidic conditions that epimerise the sensitive C‑4′ stereocenter. The deprotected natural product is purified by reverse-phase prep HPLC (C18, acetonitrile/water with 0.1% formic acid) and exhibits specific rotation [α]D = +12.7° (c 0.15, MeOH), matching the literature reference within ± 1°. The entire route comprises 12 steps with an overall yield of 4.8%, and the boronic acid`s reliability in the initial oxidative-addition prone double coupling was considered the enabling factor, as palladium black formation was suppressed by the carbamate stabilising the low-valent Pd intermediate.